Related Experiment Video
Updated: Aug 11, 2026

12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
[Disseminated lupus erythematosis: current therapies and future hopes]
1Service de Rhumatologie, Cliniques Universitaires Saint-Luc, Universitaires Saint-Luc, Université catholique de Louvain.
Abstract:
The author summarizes his recent scientific achievements in the field of systemic lupus erythematosus, with special emphasis on the role of certain cytokines in the pathophysiology of the disease, the treatment of kidney involvement and glucocorticoid-induced bone manifestations.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.